EXAGEN INC. - COMMON STOCK

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

30 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance

07 янв 2024 12:00:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Third Quarter 2023 Results

13 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers

09 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

02 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023

30 окт 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting

28 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

12 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Second Quarter 2023 Results

07 авг 2023 08:00:01 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference

26 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023

25 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference

30 май 2023 09:00:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2023 Results

15 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Announces Campaign for Lupus Awareness Month

01 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023

24 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

20 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023

06 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in Upcoming March Conferences

27 фев 2023 09:00:01 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

30 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

23 янв 2023 09:00:00 Источник Nasdaq GlobeNewswire